Literature DB >> 10964100

Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue.

J A Williams1, F L Martin, G H Muir, A Hewer, P L Grover, D H Phillips.   

Abstract

Epidemiological evidence suggests a link between meat consumption and prostate cancer. In this study, benign prostatic hyperplasia tissues, obtained by transurethral resection or radical retropubic prostatectomy from UK-resident individuals (n = 18), were examined for CYP1 expression and for their ability, in short-term organ culture, to metabolically activate carcinogens found in cooked meat. Semi-quantitative RT-PCR analysis of CYP1 expression detected CYP1A2 mRNA transcripts in the prostates of four individuals, as well as mRNA transcripts from CYP1A1 and CYP1B1. The compounds tested for metabolic activation were 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP; 500 microM, n = 9) and its metabolite N:-hydroxy PhIP (20 microM, n = 8), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ; 500 microM, n = 6) and benzo[a]pyrene (B[a]P; 50 microM, n = 5). After incubation (PFMR medium, 22 h, 37 degrees C), DNA was isolated from tissue fragments and DNA adducts were detected and quantified by (32)P-postlabelling analysis. DNA adduct formation was detected in all samples incubated with PhIP (mean, adducts per 10(8) nucleotides), N:-hydroxy-PhIP (2736/10(8)) or B[a]P (1/10(8)). IQ-DNA adducts were detected in 5/6 tissues (mean, 1/10(8)). The CYP1 inhibitor alpha-naphthoflavone (10 microM) reduced B[a]P-DNA adduct formation in tissues from two individuals by 96 and 64%, respectively. This pilot study shows that human prostate tissue can metabolically activate 'cooked meat' carcinogens, a process that could contribute to prostate cancer development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964100     DOI: 10.1093/carcin/21.9.1683

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 2.  Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.

Authors:  Benjamin A Rybicki; Nora L Nock; Adnan T Savera; Deliang Tang; Andrew Rundle
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

3.  Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Authors:  Inik Chang; Shinichiro Fukuhara; Darryn K Wong; Ankurpreet Gill; Yozo Mitsui; Shahana Majid; Sharanjot Saini; Soichiro Yamamura; Takeshi Chiyomaru; Hiroshi Hirata; Koji Ueno; Sumit Arora; Varahram Shahryari; Guoren Deng; Z Laura Tabatabai; Kirsten L Greene; Dong Min Shin; Hideki Enokida; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Tumour Biol       Date:  2014-07-17

4.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

Review 5.  Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Authors:  Slobodan P Rendic; Frederick P Guengerich
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

6.  Biotin supplementation decreases the expression of the SERCA3 gene (ATP2A3) in Jurkat cells, thus, triggering unfolded protein response.

Authors:  Jacob B Griffin; Rocio Rodriguez-Melendez; Leonard Dode; Frank Wuytack; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2005-06-13       Impact factor: 6.048

7.  Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Michelle Jankowski; Sheri Trudeau; Andrew Rundle; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2012-10-12       Impact factor: 4.944

8.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

9.  Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate.

Authors:  Deliang Tang; Jason J Liu; Cathryn H Bock; Christine Neslund-Dudas; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

10.  Effects of benzo(a)pyrene on intra-testicular function in F-344 rats.

Authors:  Anthony E Archibong; Aramandla Ramesh; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Donald D Lunstra
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.